BioSpace News Archive

The prevalence of rare diseases has surged in recent years, as the tracking of their incidence has improved around the world in the past few decades.

The global Guillain–Barré syndrome market was valued at US$ 454.0 Mn in 2016 and is expected to expand at a high CAGR of 5% from 2017 to 2025, to reach value of US$ 708.6 Mn by 2025, according to a new report published by Transparency Market Research titled “Guillain–Barré Syndrome Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025.”

The global glaucoma treatment market is competitive in nature with a large number of players operating in it across the globe, states a new market research study by Transparency Market Research.

The global market for drug and gene delivery systems features a largely consolidated vendor landscape with only a handful companies accounting for a dominant share in the overall market, observes Transparency Market Research in a recent report.

Current and ongoing clinical trials in oncology have shed light on multifactorial pathogenicity of the syndrome cancer cachexia.

The global bone marrow aspirate concentrates market was valued around US$ 130.0 Mn in 2016 is anticipated to register a stable CAGR of over 5.0% during forecast period of 2017 to 2025, according to a new report published by Transparency Market Research titled “Bone Marrow Aspirate Concentrates Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.

The anti-infective viral drugs to witness robust growth as infectious diseases continue to rise amidst changing weather patterns globally.

Eurofins U.S. Clinical Diagnostics announced the launch date of its pooled PCR test to detect SARS-CoV-2 and significantly reduce the price per PCR test for clients.

PureTech Health plc announced that Bharatt Chowrira, J.D., Ph.D., president and chief of business and strategy, will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 12, at 9:10AM EDT.

ANGLE plc, a world-leading liquid biopsy company, announces that its Annual General Meeting will be held at 2:00 pm on Thursday 27 August 2020 as a closed meeting at ANGLE plc, 10 Nugent Road, Surrey Research Park, Guildford, GU2 7AF.